Penn Medicine Provider
Hematology
Sandra P. Susanibar-Adaniya, MD
5.0
(301)
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 4th Floor West

About me

  • Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: National University of San Marcos
  • Residency: Hospital Nacional Edgardo Rebagliati Martins
  • Residency: University of Arkansas for Medical Sciences
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

301 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

July 2025
5.0
5.0
she's the best
June 2025
5.0
5.0
all my questions are addressed.
June 2025
5.0
5.0
the "bedside manner", knowledge, and concern for my particular case was reassuring to say the least.
June 2025
5.0
5.0
knowledgeable.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Susanibar-Adaniya is a Penn Medicine physician.

Qualifications and experience

My research

Beatrice M. Razzo; Shonali Midha; Andrew J. Portuguese ; Ariel F. Grajales-Cruz; Andre De Menezes Silva Corraes ; Patrick Costello; Yuxin Liu; Adam S. Sperling; Omar Nadeem ; Danai Dima; Rahul Banerjee; Andrew J.Rowan; Aimaz Afrough; Larry D. Anderson; Alex Lieberman-Cribbin; Gurbakhash Kaur; Anmol Goyal; Shebli Atrash; Christopher J. Ferreri; Peter M. Voorhees; Oren Pasvolsky; Hans C. Lee; Krina K. Patel; Kelley L. Julian; Peter A. Forsberg; Megan M. Herr; Saurabh Chhabra; Ricardo D. Parrondo; Yi Lin; Anna Chen; Sandra P. Susanibar-Adaniya; Jack Khouri; Shahzad Raza; Faiz Anwer; Mariola Vazquez-Martinez; Omar Castaneda Puglianini ; Douglas W. Sborov; James A. Davis ; Adriana Rossi; Leyla Shune; Jenny Bhurtel; Wei-Ting Hwang; Doris K. Hansen; Surbhi Sidana; Alfred L. Garfall;Shambavi Richard Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy Consortium , Blood Cancer Discovery: 2025


Luca Paruzzo, Khashayar Eshaghi, Guido Ghilardi, Abigail Doucette, Matthew Ho, Alberto Carturan, Dan T. Vogl, Adam J. Waxman, Shivani Kapur, Eugenio Fardella, Martina Pucillo, Antonio Imparato, Federico Stella, Puneeth Guruprasad, Vitor B. De Souza, Luke Maillie, Sofia Kaparis, Riemke Bouvier Bs, Adam D. Cohen, Jalpa A. Doshi, David L. Porter, Alfred L. Garfall, , Edward A. Stadtmauer, Carmen E. Guerra, Sandra P. Susanibar Adaniya, Marco Ruella Access and Outcomes of Racial and Ethnic Minority Populations Receiving Commercial Anti-BCMA CART for Myeloma , Blood Immunology & Cellular Therapy: 2025


Oren Pasvolsky, Danai Dima, Lei Feng, Wenli Dong, Tiffany Richards, James A Davis, Aimaz Afrough, Mariola Vazquez-Martinez, Aishwarya Sannareddy, Utkarsh Goel, Rahul Banerjee, Jack Khouri, Frances Cervoni, Mahmoud R Gaballa, Alex Lieberman-Cribbin, Masooma Shifa Rana, Kelley Julian, Christopher J Ferreri, Leyla Shune, Shaun DeJarnette, Evguenia Bhurtel, Sandra Susanibar Adaniya 13, Andrew Portuguese 2, Hitomi Hosoya 9, Lekha Mikkilineni 9, Gurbakhash Kaur, Adriana Rossi, Megan M Herr, Daniel Schrum, Chenyu Lin, Shahzad Raza, Yi Lin, Shonali Midha, Nadeem Omar, Shebli Atarsh, Joseph McGuirk, Douglas Sborov, Peter Voorhees, Faiz Anwer, Melissa Alsina, Ciara Freeman, Alfred L Garfall, Beatrice M Razzo, Surbhi Sidana, Andrew J Cowan, Larry D Anderson Jr, Doris K Hansen, Shambavi Richard, Krina K Patel, Hans C Lee, Ariel Grajales-Cruz Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium , Blood Cancer Journal: 2025


Xinhe Shan, Rowan Kuiper, Chuling Ding, Pashna N Munshi, Edward A Stadtmauer, Sandra P Susanibar-Adaniya Age-related disparities in treatment and outcomes for newly diagnosed multiple myeloma: a population-based study , Haematologica : 2025


Dima D, Afrough A, Goel U, Grajales-Cruz A, Khouri J, Julian K, Pasvolsky O, Banerjee R, Razzo B, Ferreri CJ, Vazquez Martinez MA, Davis JA, Sannareddy A, Castaneda Puglianini O, Raza S, Portuguese AJ, Gaballa MR, Rana M, Lieberman-Cribbin A, DeJarnette S, Gonzalez R, Chen A, Herr MM, Mikkilineni L, Hosoya H, Ouchveridze E, Kaur G, Rossi AC, Shune L, Anwer F, Lin Y, Richard S, Sborov DW, Baz RC, Garfall A, Lee HC, Anderson LD Jr, Cowan AJ, Patel KK, Voorhees PM, Sidana S, Hansen DK, Atrash S, Susanibar-Adaniya SP. Teclistamab for Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma and Renal Impairment , Blood Advances: 2025


Matthew Ho, Luca Paruzzo, Janna Minehart, Teja Voruganti, Pooja Devi, Dan T. Vogl, Adam D. Cohen, Alfred L. Garfall, Adam J. Waxman, Shivani Kapur, Edward A. Stadtmauer, Sandra Susanibar Adaniya, Sarah Longworth Nontuberculous mycobacterial infections following teclistamab in multiple myeloma , Haematologica: 2025


Guido Ghilardi, Zainul S. Hasanali, Sandra P. Susanibar-Adaniya, Lena E. Winestone, Marco Ruella and Alfred L. Garfall Association of age, race, and ethnicity with access, response, and toxicities from CAR-T therapy in children and adults with B-cell malignancies: a review , Journal for ImmunoTherapy of Cancer, 13: 2025


Margaret Stalker, Alfred Garfall, Adam Cohen, Dan T. Vogl, Mia Djulbegovic, Sandra Susanibar-Adaniya, Edward Stadtmauer, Oxana Megherea, Adam J. Waxman Safety and Efficacy of Teclistamab in Patients With Relapsed or Refractory AL Amyloidosis , European Journal of Hematology : 2024


Omar Elghawy, Saarang Deshpande, Jonathan Sussman, Alfred Garfall, Adam Cohen, Shivani Kapur, Sandra Susanibar-Adaniya, Dan Vogl, Adam Waxman, Edward Stadtmauer Characteristics and outcomes of therapy-related acute leukemia following autologous transplant (Auto-HCT) for multiple myeloma. , Bone Marrow Transplantation: 2024


Zainul S Hasanali, Alfred L Garfall, Lisa Burzenski, Leonard D Shultz, Yan Tang, Siddhant Kadu, Neil C Sheppard, Derek Dopkin, Dan T Vogl, Adam D Cohen, Adam J Waxman, Sandra P Susanibar-Adaniya, Martin Carroll, Edward A Stadtmauer, David Allman Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice , JCI Insight , 10: 2024,e177300